Fareva and ApiJect Systems entered a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect’s prefilled injector technology. Fareva plans to invest more than $56.5 million for these three manufacturing lines, with support from the Government of France, through the “France Relance” industry initiative and...